Bank of New York Mellon Corp Sells 5,995 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Bank of New York Mellon Corp reduced its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 3.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 186,186 shares of the medical instruments supplier's stock after selling 5,995 shares during the quarter. Bank of New York Mellon Corp owned 0.76% of ICU Medical worth $25,854,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Harvest Fund Management Co. Ltd acquired a new stake in shares of ICU Medical during the 4th quarter valued at $33,000. Quarry LP boosted its stake in shares of ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after buying an additional 214 shares during the period. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical during the 4th quarter valued at $52,000. Russell Investments Group Ltd. boosted its stake in shares of ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 300 shares during the period. Finally, GAMMA Investing LLC grew its position in ICU Medical by 27.2% in the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 153 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Stock Performance

Shares of ICU Medical stock traded down $2.25 during trading on Friday, reaching $122.47. The company's stock had a trading volume of 139,373 shares, compared to its average volume of 255,986. The business's 50-day moving average price is $132.57 and its 200-day moving average price is $143.90. The firm has a market cap of $3.01 billion, a PE ratio of -31.98 and a beta of 0.87. ICU Medical, Inc. has a 52 week low of $117.92 and a 52 week high of $196.26. The company has a quick ratio of 1.52, a current ratio of 2.59 and a debt-to-equity ratio of 0.75.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.49. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The business had revenue of $599.49 million during the quarter, compared to analysts' expectations of $574.15 million. During the same quarter in the prior year, the business posted $0.96 earnings per share. ICU Medical's revenue was up 6.7% compared to the same quarter last year. Equities analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Transactions at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 5,556 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was sold at an average price of $138.65, for a total transaction of $770,339.40. Following the transaction, the chief operating officer directly owned 2,389 shares in the company, valued at approximately $331,234.85. This represents a 69.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director David C. Greenberg sold 1,942 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $143.66, for a total value of $278,987.72. Following the transaction, the director owned 6,760 shares in the company, valued at $971,141.60. The trade was a 22.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 36,097 shares of company stock worth $4,860,156. 1.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have commented on ICUI shares. Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. KeyCorp decreased their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, Raymond James Financial dropped their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research note on Friday, May 9th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $192.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.